For the approximately 7,000 known rare diseases, less than 10% of diseases have an FDA-approved treatment available. Due to a small number of patients, limited understanding of the variability and progression of the diseases, developing a drug or treatment for rare diseases is often challenging. Rare diseases currently affect 3.5% – 5.9% of the worldwide […]

Read More →

The U.S. represents the largest continental pharma market worldwide and holds around 45% of the global market The US pharmaceutical market is projected to increase from $354bn in 2015 to $497bn by 2020, according to a report. Though markets like china and Indian have shown a great leap in the pharma market, the United States […]

Read More →

Exploring the region that conducts most clinical trials in the world and is the flag bearer for most clinical research studies, requires considering many factors and areas. In first part of this series of article for Clinical Trials in United States, regulatory situation, site and investigators were discussed. In this part, we will be knowing about […]

Read More →